Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A study suggests that pre-exposure prophylaxis (PrEP) pills work at full potency in women of trans experience who use feminizing hormones.
Studies offer reassurance that transgender women can safely and effectively use PrEP with hormone therapy.
The “No Data No More” manifesto explains why it’s vital to include more transgender people in HIV prevention research. [VIDEO]
Study will test whether providing both together will improve HIV protection for trans women.
The REPRIEVE study, which is primarily looking at a statin’s effect on cardiovascular disease, is shedding light on many other mysteries.
PrEP may be less effective among trans women compared with men who have sex with men.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.